Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition

Hyperuricemia is a high-risk factor for the development of gout and renal fibrosis, but the adverse effects of hyperuricemia on the liver have been seriously neglected. This research investigated the ameliorating effect of Lacticaseibacillus rhamnosus Fmb14 on hyperuricemia induced liver dysfunction...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongyuan Zhao, Xiaoyu Chen, Li Zhang, Fanqiang Meng, Libang Zhou, Zhaoxin Lu, Yingjian Lu
Format: Article
Language:English
Published: Tsinghua University Press 2024-07-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2022.9250181
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550160599973888
author Hongyuan Zhao
Xiaoyu Chen
Li Zhang
Fanqiang Meng
Libang Zhou
Zhaoxin Lu
Yingjian Lu
author_facet Hongyuan Zhao
Xiaoyu Chen
Li Zhang
Fanqiang Meng
Libang Zhou
Zhaoxin Lu
Yingjian Lu
author_sort Hongyuan Zhao
collection DOAJ
description Hyperuricemia is a high-risk factor for the development of gout and renal fibrosis, but the adverse effects of hyperuricemia on the liver have been seriously neglected. This research investigated the ameliorating effect of Lacticaseibacillus rhamnosus Fmb14 on hyperuricemia induced liver dysfunction both in vitro and in vivo. Cell free extracts of high dose L. rhamnosus Fmb14 treatment reduced the death rate of HepG2 cell lines from 24.1% to 14.9% by inhibiting NLRP3 recruitment, which was mainly activated by reactive oxygen species release and mitochondrial membrane potential disorder. In purine dietary induced hyperuricemia (PDIH) mice model, liver oedema and pyroptosis were ameliorated after L. rhamnosus Fmb14 administration through downregulating the expression levels of NLRP3, caspase-1 and gasdermin-D from 1.61 to 0.86, 3.15 to 1.01 and 5.63 to 2.02, respectively. L. rhamnosus Fmb14 administration restored mitochondrial inner membrane protein (MPV17) and connexin 43 from 2.83 and 0.73 to 0.80 and 0.98 respectively in PDIH mice, indicating that dysbiosis of mitochondrial membrane potential was restored in liver. Intriguingly, PDIH pyroptosis stimulates the process of apoptosis, which leads to severe leakage of hepatocytes, and both of pyroptosis and apoptosis were decreased after L. rhamnosus Fmb14 treatment. Therefore, L. rhamnosus Fmb14 is a promising biological resource to maintain homeostasis of the liver in hyperuricemia and the prevention of subsequent complications.
format Article
id doaj-art-15ecc3e58a014d15adabd0903c34af48
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2024-07-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-15ecc3e58a014d15adabd0903c34af482025-01-10T06:56:48ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-07-011342174218610.26599/FSHW.2022.9250181Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibitionHongyuan Zhao0Xiaoyu Chen1Li Zhang2Fanqiang Meng3Libang Zhou4Zhaoxin Lu5Yingjian Lu6College of Food Science & Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science & Technology, Nanjing Agricultural University, Nanjing 210095, ChinaInstitute of Vegetable, Gansu Academy of Agricultural Sciences, Lanzhou 730070, ChinaCollege of Food Science & Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science & Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science & Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science & Engineering, Nanjing University of Finance and Economics, Nanjing 210023, ChinaHyperuricemia is a high-risk factor for the development of gout and renal fibrosis, but the adverse effects of hyperuricemia on the liver have been seriously neglected. This research investigated the ameliorating effect of Lacticaseibacillus rhamnosus Fmb14 on hyperuricemia induced liver dysfunction both in vitro and in vivo. Cell free extracts of high dose L. rhamnosus Fmb14 treatment reduced the death rate of HepG2 cell lines from 24.1% to 14.9% by inhibiting NLRP3 recruitment, which was mainly activated by reactive oxygen species release and mitochondrial membrane potential disorder. In purine dietary induced hyperuricemia (PDIH) mice model, liver oedema and pyroptosis were ameliorated after L. rhamnosus Fmb14 administration through downregulating the expression levels of NLRP3, caspase-1 and gasdermin-D from 1.61 to 0.86, 3.15 to 1.01 and 5.63 to 2.02, respectively. L. rhamnosus Fmb14 administration restored mitochondrial inner membrane protein (MPV17) and connexin 43 from 2.83 and 0.73 to 0.80 and 0.98 respectively in PDIH mice, indicating that dysbiosis of mitochondrial membrane potential was restored in liver. Intriguingly, PDIH pyroptosis stimulates the process of apoptosis, which leads to severe leakage of hepatocytes, and both of pyroptosis and apoptosis were decreased after L. rhamnosus Fmb14 treatment. Therefore, L. rhamnosus Fmb14 is a promising biological resource to maintain homeostasis of the liver in hyperuricemia and the prevention of subsequent complications.https://www.sciopen.com/article/10.26599/FSHW.2022.9250181lacticaseibacillus rhamnosus fmb14hyperuricemiapyroptosisnlrp3 pathway
spellingShingle Hongyuan Zhao
Xiaoyu Chen
Li Zhang
Fanqiang Meng
Libang Zhou
Zhaoxin Lu
Yingjian Lu
Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
Food Science and Human Wellness
lacticaseibacillus rhamnosus fmb14
hyperuricemia
pyroptosis
nlrp3 pathway
title Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
title_full Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
title_fullStr Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
title_full_unstemmed Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
title_short Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
title_sort lacticaseibacillus rhamnosus fmb14 ameliorates hyperuricemia induced hepatocyte pyroptosis via nlrp3 inflammasome cascade inhibition
topic lacticaseibacillus rhamnosus fmb14
hyperuricemia
pyroptosis
nlrp3 pathway
url https://www.sciopen.com/article/10.26599/FSHW.2022.9250181
work_keys_str_mv AT hongyuanzhao lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition
AT xiaoyuchen lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition
AT lizhang lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition
AT fanqiangmeng lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition
AT libangzhou lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition
AT zhaoxinlu lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition
AT yingjianlu lacticaseibacillusrhamnosusfmb14ameliorateshyperuricemiainducedhepatocytepyroptosisvianlrp3inflammasomecascadeinhibition